The role of bile salt toxicity in the pathogenesis of bile duct injury after non-heart-beating porcine liver transplantation

Transplantation

Volumn 85, Issue 11, 2008, Pages 1625-1631

  Yska, Marit J ^a   Buis, Carlijn I ^a   Monbaliu, Diethard ^b   Schuurs, Theo A ^a   Gouw, Annette S H ^a   Kahmann, Olivier N H ^a   Visser, Dorien S ^a   Pirenne, Jacques ^b   Porte, Robert J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

ABC transporters; Bile duct injury; Bile salts; Non heart beating liver transplantation; Phospholipids

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILE SALT; BILIRUBIN; ABC TRANSPORTER; ABCB11 PROTEIN, MOUSE; ABCB11 PROTEIN, RAT; BILE ACID; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE COMPOSITION; BILE DUCT INJURY; BILE FLOW; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; GRAFT SURVIVAL; HEART ARREST; HISTOPATHOLOGY; ISCHEMIA; LIVER TRANSPLANTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN PRESERVATION; ORGAN TRANSPLANTATION; PATHOGENESIS; PRIORITY JOURNAL; SWINE; ANIMAL; BIOPSY; BIOSYNTHESIS; COMPARATIVE STUDY; DISEASE MODEL; GENE EXPRESSION; GENETICS; HOSPITALIZATION; INJURY; INTRAHEPATIC BILE DUCT; INTRAHEPATIC CHOLESTASIS; METABOLISM; MORTALITY; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SURVIVAL RATE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BILE ACIDS AND SALTS; BILE DUCTS, INTRAHEPATIC; BIOPSY; CHOLESTASIS, INTRAHEPATIC; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; LIVER TRANSPLANTATION; P-GLYCOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; SWINE;

EID: 47049107902     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318170f5f7     Document Type: Article

References (35)

1. Recommendations for nonheartbeating organ donation. A position paper by the Ethics Committee, American College of Critical Care Medicine, Society of Critical Care Medicine. Crit Care Med 2001; 29: 1826.
2. Neuberger J. Developments in liver transplantation. Gut 2004; 53: 759.
3. Reddy S, Zilvetti M, Brockmann J, et al. Liver transplantation from non-heart-beating donors: Current status and future prospects. Liver Transpl 2004; 10: 1223.
4. Zawistowski CA, Devita MA. Non-heartbeating organ donation: A review. J Intensive Care Med 2003; 18: 189.
5. Abt P, Crawford M, Desai N, et al. Liver transplantation from controlled non-heart-beating donors: An increased incidence of biliary complications. Transplantation 2003; 75: 1659.
6. Abt PL, Desai NM, Crawford MD, et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg 2004; 239: 87.
7. Garcia-Valdecasas JC, Tabet J, Valero R, et al. Evaluation of ischemic injury during liver procurement from non-heart-beating donors. Eur Surg Res 1999; 31: 447.
8. Lewis WD, Jenkins RL. Biliary strictures after liver transplantation. Surg Clin North Am 1994; 74: 967.
9. Verdonk RC, Buis CI, Porte RJ, et al. Biliary complications after liver transplantation: A review. Scand J Gastroenterol Suppl 2006: 243: 89.
10. Strazzabosco M, Fabris L, Spirli C. Pathophysiology of cholangiopa-thies. J Clin Gastroenterol 2005; 39: S90.
11. Cameron AM, Busuttil RW. Ischemic cholangiopathy after liver transplantation. Hepatobiliary Pancreat Dis Int 2005; 4: 495.
12. Noack K, Bronk SF, Kato A, et al. The greater vulnerability of bile duct cells to reoxygenation injury than to anoxia. Implications for the pathogenesis of biliary strictures after liver transplantation. Transplantation 1993; 56: 495.
13. Lazaridis KN, Strazzabosco M, Larusso NF. The cholangiopathies: Disorders of biliary epithelia. Gastroenterology 2004; 127: 1565.
14. Geuken E, Visser D, Kuipers F, et al. Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation. J Hepatol 2004; 41: 1017.
15. Hertl M, Harvey PR, Swanson PE, et al. Evidence of preservation injury to bile ducts by bile salts in the pig and its prevention by infusions of hydrophilic bile salts. Hepatology 1995; 21: 1130.
16. Hoekstra H, Porte RJ, Tian Y, et al. Bile salt toxicity aggravates cold ischemic injury of bile ducts after liver transplantation in Mdr2+/ - mice. Hepatology 2006; 43:1022.
17. Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. NEngl JMed 1998; 339: 1217.
18. Monbaliu D, Crabbe T, Roskams T, et al. Livers from non-heart-beating donors tolerate short periods of warm ischemia. Transplantation 2005; 79: 1226.
19. Monbaliu D, van Pelt J, De Vos R, et al. Primary graft nonfunction and Kupffer cell activation after liver transplantation from non-heart-beating donors in pigs. Liver Transpl 2007; 13: 239.
20. Oike F, Uryuhara K, Otsuka M, et al. Simplified technique of orthotopic liver transplantation in pigs. Transplantation 2001; 71: 328.
21. Turley SD, Dietschy JM. Re-evaluation of the 3 alpha-hydroxysteroid dehydrogenase assay for total bile acids in bile. J Lipid Res 1978; 19:924.
22. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997; 25: 658.
23. Schmucker DL, Ohta M, Kanai S, et al. Hepatic injury induced by bile salts: Correlation between biochemical and morphological events. Hepatology 1990; 12: 1216.
24. Buis CI, Hoekstra H, Verdonk RC, et al. Causes and consequences of ischemic-type biliary lesions after liver transplantation. J Hepatobiliary Pancreat Surg 2006; 13:517.
25. Arrese M, Trauner M. Molecular aspects of bile formation and cholestasis. Trends Mol Med2003; 9: 558.
26. de Vree JM, Jacquemin E, Sturm E, et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 1998; 95: 282.
27. Deleuze JF, Jacquemin E, Dubuisson C, et al. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 1996; 23: 904.
28. Jacquemin E, de Vree JM, Cresteil D, et al. The wide spectrum of multidrug resistance 3 deficiency: From neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001; 120: 1448.
29. Suchy FJ, Ananthanarayanan M. Bile salt excretory pump: Biology and pathobiology. JPediatr Gastroenterol Nutr 2006; 43(suppl 1): S10.
30. Trauner M, Boyer JL. Bile salt transporters: Molecular characterization, function, and regulation. Physiol Rev 2003; 83: 633.
31. Fickert P, Zollner G, Fuchsbichler A, et al. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 2001; 121: 170.
32. Trauner M, Fickert P, Wagner M. MDR3 (ABCB4) defects: A paradigm for the genetics of adult cholestatic syndromes. Semin Liver Dis 2007; 27: 77.
33. Miranda S, Vollrath V, Wielandt AM, et al. Overexpression of mdr2 gene by peroxisome proliferators in the mouse liver. J Hepatol 1997; 26: 1331.
34. Hooiveld GJ, Vos TA, Scheffer GL, et al. 3-Hydroxy-3-methylglutaryl- coenzyme A reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in rats. Gastroenterology 1999; 117: 678.
35. Chianale J, Vollrath V, Wielandt AM, et al. Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse. Biochem J 1996; 314: 781.